Zacks
Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves
📊
AI Sentiment
Positive
7/10
- Home
- HIMS
as of 12-10-2025 3:45pm EST
$37.98
$1.69
-4.25%
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Chart Type:
Time Range:
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 8.9B | IPO Year: | N/A |
| Target Price: | $44.90 | AVG Volume (30 days): | 19.6M |
| Analyst Decision: | Hold | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.54 | EPS Growth: | 20.76 |
| 52 Week Low/High: | $23.97 - $72.98 | Next Earning Date: | 11-03-2025 |
| Revenue: | $2,210,958,000 | Revenue Growth: | 78.02% |
| Revenue Growth (this year): | 62.21% | Revenue Growth (next year): | 18.79% |
AI-Powered HIMS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 77.42%
77.42%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
Perez Garcia Andrea G
Sell
Director
HIMS Dec 9, 2025
Avg Cost/Share
$39.17
Shares
2,500
Total Value
$97,925.00
Owned After
80,166
SEC Form 4
Boughton Soleil
Sell
Chief Legal Officer
HIMS Nov 24, 2025
Avg Cost/Share
$35.22
Shares
2,631
Total Value
$92,663.82
Owned After
153,225
SEC Form 4
Okupe Oluyemi
Sell
Chief Financial Officer
HIMS Nov 17, 2025
Avg Cost/Share
$36.81
Shares
23,187
Total Value
$853,490.28
Owned After
70,232
SEC Form 4
Boughton Soleil
Sell
Chief Legal Officer
HIMS Nov 10, 2025
Avg Cost/Share
$42.53
Shares
2,637
Total Value
$112,151.61
Owned After
153,225
SEC Form 4
Boughton Soleil
Sell
Chief Legal Officer
HIMS Oct 27, 2025
Avg Cost/Share
$50.10
Shares
2,637
Total Value
$132,113.70
Owned After
153,225
SEC Form 4
Okupe Oluyemi
Sell
Chief Financial Officer
HIMS Oct 17, 2025
Avg Cost/Share
$57.13
Shares
11,592
Total Value
$662,221.98
Owned After
70,232
SEC Form 4
Dudum Andrew
Sell
Chief Executive Officer
HIMS Oct 16, 2025
Avg Cost/Share
$62.94
Shares
175,661
Total Value
$11,029,998.77
Owned After
47,524
Boughton Soleil
Sell
Chief Legal Officer
HIMS Oct 13, 2025
Avg Cost/Share
$54.38
Shares
2,637
Total Value
$143,400.06
Owned After
153,225
SEC Form 4
Chi Michael
Sell
Chief Commercial Officer
HIMS Oct 10, 2025
Avg Cost/Share
$58.25
Shares
900
Total Value
$52,425.00
Owned After
291,439
SEC Form 4
Okupe Oluyemi
Sell
Chief Financial Officer
HIMS Oct 3, 2025
Avg Cost/Share
$57.72
Shares
11,595
Total Value
$669,232.09
Owned After
70,232
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Perez Garcia Andrea G | HIMS | Director | Dec 9, 2025 | Sell | $39.17 | 2,500 | $97,925.00 | 80,166 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Nov 24, 2025 | Sell | $35.22 | 2,631 | $92,663.82 | 153,225 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Nov 17, 2025 | Sell | $36.81 | 23,187 | $853,490.28 | 70,232 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Nov 10, 2025 | Sell | $42.53 | 2,637 | $112,151.61 | 153,225 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Oct 27, 2025 | Sell | $50.10 | 2,637 | $132,113.70 | 153,225 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Oct 17, 2025 | Sell | $57.13 | 11,592 | $662,221.98 | 70,232 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Oct 16, 2025 | Sell | $62.94 | 175,661 | $11,029,998.77 | 47,524 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Oct 13, 2025 | Sell | $54.38 | 2,637 | $143,400.06 | 153,225 | |
| Chi Michael | HIMS | Chief Commercial Officer | Oct 10, 2025 | Sell | $58.25 | 900 | $52,425.00 | 291,439 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | Oct 3, 2025 | Sell | $57.72 | 11,595 | $669,232.09 | 70,232 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
The Wall Street Journal
Stocks to Watch Thursday: Salesforce, Meta, Kroger, Dollar General
Insider Monkey
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
The Wall Street Journal
Hims & Hers Stock Gains on Move Into Canada
Compare HIMS vs Leading Stocks
See how HIMS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.